CEO trust sale at Novanta (NASDAQ: NOVT) unloads 7,500 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Novanta Inc. disclosed that a trust associated with Chief Executive Officer and director Matthijs Glastra sold common stock under a pre-established trading plan. On January 21, 2026, the entity sold 7,500 shares of Novanta common stock at $140 per share in an open-market transaction. After this sale, Glastra remained beneficial owner of 71,367 shares held directly, and 54,382 shares held indirectly through the Matthijs Glastra 2021 Irrevocable Trust. The filing notes that these sales were made under a Rule 10b5-1 trading plan adopted on September 11, 2025 through a trust for which the reporting person’s spouse is a trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 7,500 shares ($1,050,000)
Net Sell
2 txns
Insider
Glastra Matthijs
Role
Chief Executive Officer
Sold
7,500 shs ($1.05M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 7,500 | $140.00 | $1.05M |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 71,367 shares (Direct);
Common Stock — 54,382 shares (Indirect, Matthijs Glastra 2021 Irrevocable Trust)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did NOVANTA INC (NOVT) report for Matthijs Glastra?
The company reported that a trust associated with Chief Executive Officer and director Matthijs Glastra sold 7,500 shares of Novanta common stock on January 21, 2026 at $140 per share.
Was the NOVT insider sale by Matthijs Glastra pre-planned under Rule 10b5-1?
Yes. The filing states the sales were made under a pre-established Rule 10b5-1 trading plan that was adopted on September 11, 2025 through a trust for which the reporting person’s spouse is a trustee.
What role does Matthijs Glastra hold at Novanta Inc. (NOVT)?
According to the filing, Matthijs Glastra is a director and Chief Executive Officer of Novanta Inc.